Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-26 6:46 pm Purchase | 2025-09-24 | 13G | Rein Therapeutics Inc. RNTX | Voss Capital LP | 2,666,532 11.300% | 1,388,676 (+108.67%) | Filing History |
| 2025-05-14 8:26 pm Purchase | 2025-05-08 | 13G | Rein Therapeutics Inc. RNTX | Voss Capital LP | 1,277,856 5.600% | 1,277,856 (New Position) | Filing History |
| 2024-11-05 5:17 pm Sale | 2024-11-04 | 13G | Rein Therapeutics Inc. RNTX | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 960,665 4.400% | -851,962 (-47.00%) | Filing History |
| 2024-04-16 5:16 pm Sale | 2024-04-02 | 13D | Rein Therapeutics Inc. RNTX | Satter Muneer A | 830,466 4.900% | -186,567 (-18.34%) | Filing History |
| 2024-03-05 7:14 pm Purchase | 2024-02-28 | 13G | Rein Therapeutics Inc. RNTX | UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,812,627 6.200% | 1,812,627 (New Position) | Filing History |
| 2024-03-05 4:30 pm Purchase | 2024-03-05 | 13D | Rein Therapeutics Inc. RNTX | Satter Muneer A | 1,017,033 5.900% | 9,545 (+0.95%) | Filing History |
| 2024-02-14 10:28 am Sale | 2023-12-31 | 13G | Rein Therapeutics Inc. RNTX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -236,835 (Position Closed) | Filing History |
| 2024-02-05 1:20 pm Unchanged | 2023-12-31 | 13G | Rein Therapeutics Inc. RNTX | Scott Kapnick | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-11-13 5:08 pm Purchase | 2023-10-31 | 13G | Rein Therapeutics Inc. RNTX | BIOS FUND I, LP | 542,256 9.990% | 542,256 (New Position) | Filing History |
| 2023-11-03 4:30 pm Purchase | 2023-10-31 | 13D | Rein Therapeutics Inc. RNTX | Satter Muneer A | 1,007,488 19.900% | 1,007,488 (New Position) | Filing History |
| 2023-02-14 11:42 am Purchase | 2022-12-31 | 13G | Rein Therapeutics Inc. RNTX | BIOTECHNOLOGY VALUE FUND L P | 236,835 5.200% | 236,835 (New Position) | Filing History |
| 2023-02-14 07:54 am Purchase | 2022-12-31 | 13G | Aileron Therapeutics, Inc. ALRN | Scott Kapnick | 379,608 8.400% | 360,627 (+1899.98%) | Filing History |
| 2022-02-14 09:02 am Purchase | 2021-12-31 | 13G | Aileron Therapeutics, Inc. ALRN | Scott Kapnick | 18,981 8.400% | 10,538 (+124.81%) | Filing History |
| 2021-02-10 09:53 am Unchanged | 2020-12-31 | 13G | Aileron Therapeutics, Inc. ALRN | Jennison Associates LLC | 3,856 3.700% | 0 (Unchanged) | Filing History |
| 2021-02-09 12:39 pm Unchanged | 2021-02-05 | 13G | Aileron Therapeutics, Inc. ALRN | PRUDENTIAL FINANCIAL INC PRU | 3,856 3.650% | 0 (Unchanged) | Filing History |
| 2021-01-19 5:21 pm Purchase | 2021-01-06 | 13G | Aileron Therapeutics, Inc. ALRN | BIOTECHNOLOGY VALUE FUND L P | 13,164 6.300% | 13,164 (New Position) | Filing History |
| 2021-01-08 4:04 pm Purchase | 2021-01-06 | 13D | Aileron Therapeutics, Inc. ALRN | Satter Muneer A | 50,852 19.900% | 22,500 (+79.36%) | Filing History |